Annual report pursuant to Section 13 and 15(d)

Note 12 - Segment Information - Financial Information Relating to Reportable Segments (Details)

v3.21.2
Note 12 - Segment Information - Financial Information Relating to Reportable Segments (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2019
Revenues, net $ 931,032 $ 738,691 $ 714,006
Operating income 237,296 157,419 146,719
Costs recognized upon sale of acquired inventory (1,565) 0 (3,739)
Gain on escrow settlement (0) 7,170 (0)
Corporate general, selling and administrative expenses (324,951) (260,583) (264,359)
Total long-lived assets 207,907 176,829  
Total intangible assets 615,968 516,545 579,429
United States and Canada [Member]      
Total long-lived assets 190,501 162,039  
Total intangible assets 594,512 499,875  
Europe [Member]      
Total long-lived assets 13,949 13,120  
Total intangible assets 9,369 12,349  
Asia [Member]      
Total long-lived assets 3,457 1,670  
Total intangible assets 12,087 4,321  
Consumables [Member]      
Revenues, net 751,985 602,642 588,979
Protein Sciences [Member] | Consumables [Member]      
Revenues, net 557,037 431,052 430,655
Diagnostics and Genomics [Member] | Consumables [Member]      
Revenues, net 194,948 171,590 158,324
Operating Segments [Member]      
Operating income 367,262 249,894 250,998
Costs recognized upon sale of acquired inventory (1,565) 0 (3,739)
Amortization of acquired intangible assets (64,239) (60,865) (58,550)
Gain on escrow settlement 0 7,169 0
Acquisition related expenses (7,114) (416) (2,282)
Restructuring costs (142) (87) 0
Stock-based compensation, inclusive of employer taxes (51,846) (34,262) (33,057)
Operating Segments [Member] | Protein Sciences [Member]      
Revenues, net 704,564 555,352 543,159
Operating income 328,837 234,929 240,919
Operating Segments [Member] | Diagnostics and Genomics [Member]      
Revenues, net 227,744 184,549 171,674
Operating income 38,425 14,965 10,079
Intersegment Eliminations [Member]      
Revenues, net (1,276) (1,210) (827)
Corporate, Non-Segment [Member]      
Corporate general, selling and administrative expenses $ (5,060) $ (4,015) $ (6,651)